These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4075617)

  • 1. Assessment of teratogenic potential of therapeutic agents: preclinical toxicology.
    Frederick GL
    Clin Invest Med; 1985; 8(4):323-7. PubMed ID: 4075617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratology.
    Staples RE
    J Assoc Off Anal Chem; 1979 Jul; 62(4):833-9. PubMed ID: 500534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mammalian models in teratology.
    Palmer AK
    Prog Clin Biol Res; 1985; 163A():97-106. PubMed ID: 3969396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preclinical research--toxicology].
    Frohberg H
    Arzneimittelforschung; 1975 Jul; 25(7a):1101-10. PubMed ID: 1242337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK
    Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of epidemiology in identifying drugs which may cause malformations--with particular reference to drugs containing sex hormones.
    Kelsey FO
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):189-95. PubMed ID: 7004099
    [No Abstract]   [Full Text] [Related]  

  • 8. The science of teratology in a regulatory setting.
    Chernoff N
    Basic Life Sci; 1985; 34():285-301. PubMed ID: 4062797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro tests in screening teratogens: considerations to aid the validation process.
    Kimmel GL
    Prog Clin Biol Res; 1985; 163C():259-63. PubMed ID: 3991628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory aspects of teratology: role of the Food and Drug Administration.
    Kelsey FO
    Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response studies with genetically homogeneous lines of mice as a teratology testing and risk-assessment procedure.
    Kalter H
    Teratology; 1981 Aug; 24(1):79-86. PubMed ID: 7302874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical safety testing of new drugs.
    Keysser CH
    Ann Clin Lab Sci; 1976; 6(2):197-205. PubMed ID: 814855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and standardization of screening methods for behavioral teratology.
    Buelke-Sam J; Kimmel CA
    Teratology; 1979 Aug; 20(1):17-29. PubMed ID: 515959
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical testing for teratogenicity and developmental toxicity: methods and limitations.
    Barrow PC
    Therapie; 2002; 57(2):109-14. PubMed ID: 12185956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Embryotoxic properties of drugs].
    Smol'nikova NM; Golovanova IV; Proĭnova VA; Skosyreva AM; Strekalova SN
    Farmakol Toksikol; 1982; 45(4):115-9. PubMed ID: 6751867
    [No Abstract]   [Full Text] [Related]  

  • 17. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A subvertebrate system for rapid determination of potential teratogenic hazards.
    Johnson EM
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):153-6. PubMed ID: 7217843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the effectiveness of various methods of testing drugs for embryotoxicity].
    Puchkov VF; Popov VB; Elinek R; Dostal M
    Arkh Anat Gistol Embriol; 1981 May; 80(5):104-10. PubMed ID: 6895176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A metabolite of a structural analog of thalidomide lacks teratogenic effect in pregnant rhesus monkeys.
    Scott WJ; Wilson JG; Helm FC
    Teratology; 1980 Oct; 22(2):183-5. PubMed ID: 7444807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.